“Thrombocytosis Is a Marker of Reduced Survival in Patients With Renal Cell carcinoma.: A Multicenter Study”. Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante 10, no. 1 (February 28, 2022): 43–48. Accessed June 3, 2026. https://www.rev-sen.ec/index.php/revista/article/view/11.